Virology News and Research

Latest Virology News and Research

DFG establishes interdisciplinary commission to strengthen pandemic research

Against the background of the current coronavirus pandemic, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish an interdisciplinary commission for pandemic research.

18 Jun 2020

Avacta provides update on Affimer therapy for COVID-19 infection

Avacta Group plc, is pleased to announce that collaborative work with the University of Glasgow has shown that Affimer reagents prevent infection.

From Avacta Life Sciences Ltd. 18 Jun 2020

Hepatitis C virus co-opts an immune protein to evade antiviral defenses

By discovering a trick the hepatitis C virus uses to evade the immune system, scientists have identified a new antiviral defense system that could be used to treat many virus infections, according to new research published today in eLife.

16 Jun 2020

Key factors to "flattening the curve": Western Washington state's COVID-19 experience

Despite having the first confirmed case of coronavirus and the first major COVID-19 outbreak in the United States, the state of Washington implemented a response plan that kept its death rate the lowest among all states that have had major outbreaks.

16 Jun 2020

Study finds self-swabbing tests for COVID-19 to be accurate and safe

Test samples collected by people who swabbed their own nasal passages yielded results for the COVID-19 virus that were as accurate as samples collected by a health care worker, according to a small study by researchers at the Stanford University School of Medicine.

12 Jun 2020

Interconnected mycobacteria remain alive for longer

The tuberculosis pathogen Mycobacterium tuberculosis can protect itself better when combined and thus stay alive longer in the air.

12 Jun 2020

Study: Only a minority of Geneva population has been infected by Covid-19 pandemic

A study carried out among 2'766 people by the University Hospitals of Geneva (HUG), the Geneva Centre for Emerging Viral Diseases, and the University of Geneva (UNIGE), Switzerland, reveals that, at the time of the decline of the Coronavirus pandemic, only 10.8% of the Geneva population had been infected with Covid-19.

12 Jun 2020

UCD spin-out awarded €4.5 million funding to help combat coronavirus pandemic

SiriusXT (https://siriusxt.com/), a University College Dublin (UCD) spin-out company, has been awarded just over €4.5 million in blended (grant and equity) funding from the European Innovation Council Accelerator Pilot programme which is part of Horizon 2020, the EU's research and innovation programme.

11 Jun 2020

Immuno-oncology may accelerate the development of treatments for COVID-19

Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or other control strategies that can help communities worldwide to address the impacts of the COVID-19 pandemic.

10 Jun 2020

GMU researchers studying effect of cannabidiol on exosome release

Fatah Kashanchi, Professor, Laboratory of Molecular Virology, School of Systems Biology, and Lance Liotta, Co-Director, Applied Proteomics and Molecular Medicine, are working to mitigate virally driven HIV pathenogenesis in the central nervous system.

5 Jun 2020

Study sheds new light on how respiratory virus breaks into cells to cause infection

New research from University of Alberta microbiologists has shed new light on how the respiratory syncytial virus (RSV)--one of the most common viral infections--breaks into our cells to cause infection.

3 Jun 2020

Ciheb awarded $4 million to support COVID-19 response activities

The Center for International Health, Education and Biosecurity at the University of Maryland School of Medicine's Institute of Human Virology was awarded $4 million from the U.S. Centers for Disease Control and Prevention to support coronavirus disease 2019 (COVID-19) response activities in Botswana, Nigeria, Malawi, and Mozambique.

2 Jun 2020

Researchers grow lung organoids from stem cells for Sars-Cov-2 research

A Bochum-based team intends to use organoids from stem cells to study the progression of Sars-CoV-2 infection and to identify antiviral substances.

28 May 2020

Universities and commercial partners team up to develop new COVID -19 test kit

A new COVID -19 test kit, which can detect the presence of the virus in six different individuals simultaneously in under 30 minutes, is one step closer to coming to market following a partnership deal with leading electronic, robotics, and software companies.

27 May 2020

New data may help understand the evolution of Austrian SARS-CoV-2 strains

216 SARS-CoV-2 genome sequences have now been completed and released in the framework of the "Mutational Dynamics of SARS-CoV-2 in Austria" project from CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in close collaboration with the Medical University of Vienna, the Medical University of Innsbruck and the Austrian Agency for Health and Food Safety (AGES).

27 May 2020

SARS-CoV-2 is uniquely adapted to infect humans

The novel coronavirus pandemic has sparked much debate on its origin, with some suggesting it may have been laboratory-grown. Previous studies, however, mentioned that it is zoonotic in nature, which means that the virus jumped from wild animals and found its way to humans.

25 May 2020

Different immune responses can occur in Covid-19, shows study

The human immune system is reactive to more than just the viral protein on which researchers have focused to date. This is relevant for tests and potential vaccines.

22 May 2020

New review discusses findings on coronavirus immunity

A new review discusses the findings from over 40 studies on coronavirus immunity and what they could mean for the Covid-19 pandemic.

22 May 2020

Bio-Techne and Kantaro Biosciences announce partnership to develop and scale production of COVID-19 serology test

Bio-Techne Corporation and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai-developed COVID-19 serology test.

From Bio-Techne 21 May 2020

New study initiated to establish the presence of SARS-CoV-2 in environmental samples

he Ministry of Science and Innovation, by way of the COVID-19 fund of the Carlos III Health Institute (ISCIII), is funding a study aimed at establishing the presence of SARS-CoV-2 in environmental samples as well as its indirect transmission potential.

20 May 2020